title: Assessment of optimum duration of therapy with oral dichloromethylene diphosphonate (clodronate) in the treatment of Paget's disease.
authors.affiliation: Department of Human Metabolism and Clinical Biochemistry, WHO Collaborating Centre for Metabolic Bone Disease, University of Sheffield Medical School, England.
authors.forename: S
authors.initials: S
authors.lastname: Khan
authors.forename: E V
authors.initials: EV
authors.lastname: McCloskey
authors.forename: K S
authors.initials: KS
authors.lastname: Eyres
authors.forename: E D
authors.initials: ED
authors.lastname: Fern
authors.forename: J A
authors.initials: JA
authors.lastname: Kanis
mesh_terms: D000284:Administration, Oral; D004002:Clodronic Acid / Q000008:administration & dosage*; D004334:Drug Administration Schedule; D006801:Humans; D010001:Osteitis Deformans / Q000188:drug therapy*; D012074:Remission Induction; D012189:Retrospective Studies
chemical_list: D004002:Clodronic Acid